Latest Healthcare Research Reports

Tag: gut microbiota market growth

  • Gut Microbiota Market Forecast Signals New Revenue Opportunities Through 2030

    Gut Microbiota Market Forecast Signals New Revenue Opportunities Through 2030

    Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

    Gut Microbiota Market Expansion From $0.76 Billion In 2026 To $1.47 Billion In 2030

    The global gut microbiota market experienced significant expansion, projected to increase from $0.65 billion in 2025 to $0.77 billion by 2026, reflecting a compound annual growth rate of 18.0%. This notable growth throughout the historical period was fueled by several factors, including a deepening comprehension of the connection between gut health and the immune system, a surge in the consumption of dietary supplements, the burgeoning functional foods sector, intensified academic exploration into microbiota, and heightened consumer consciousness regarding digestive well-being.

    The microbiome therapeutics market is poised for significant expansion, with projections indicating a value of $1.47 billion by 2030, reflecting a compounded annual growth rate of 17.7% during this period. This upward trajectory is anticipated to be fueled by advancements in therapies aimed at the microbiome, heightened financial backing for gut health studies, the proliferation of individualized nutritional approaches, greater incorporation of microbiome-based diagnostics, and an escalating emphasis on proactive health strategies. Key developments expected to shape this market include a broader acceptance of probiotic and prebiotic offerings, a amplified concentration on bespoke dietary plans, intensified research into treatments derived from the microbiome, and an increase in the consumption of foods that are both functional and fermented, alongside more sophisticated utilization of diagnostic instruments for assessing gut health.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=23411&type=smp

    Gut Microbiota Market Growth Momentum: Which Factors Are Influencing Demand?

    The expansion of the gut microbiota market is anticipated to be fueled by the increasing interest in personalized medicine. This approach to healthcare focuses on customizing therapies based on a patient’s unique genetic makeup, environmental influences, and daily habits, ultimately aiming to enhance therapeutic results and elevate the standard of care. As technological progress in genomics and biotechnology allows for a more accurate understanding of genetic predispositions, the development of treatments specifically designed for individuals, thereby boosting efficacy and minimizing adverse reactions, is gaining traction. In relation to gut microbiota, personalized medicine plays a crucial role by developing therapies that consider an individual’s specific microbiome profile, thereby fostering optimal gut health and leading to better management of digestive and metabolic conditions. Demonstrating this trend, the U.S. Food and Drug Administration (FDA) authorized 26 novel personalized medicines in 2023, a notable increase from the 12 approvals in 2022, according to the Personalized Medicine Coalition (PMC), a non-profit entity based in the United States, as reported in February 2024. Consequently, the escalating demand for personalized medicine is acting as a significant catalyst for the growth of the gut microbiota market.

    Gut Microbiota Market Segment Landscape: Which Areas Lead Market Development?

    The gut microbiota market covered in this report is segmented –

    1) By Product: Prebiotics, Probiotics, Drugs, Supplements, Other Products

    2) By Application: Digestive Health, Immune Health, Weight Management, Mental Health, Cardiovascular Health

    3) By Distribution Channel: Pharmacies And Drugstores, Online Retail, Health Food Stores, Supermarkets And Hypermarkets, Specialty Stores

    4) By End-Users: Adults, Children, Elderly

    Subsegments:

    1) By Prebiotics: Fructooligosaccharides (Fos), Galactooligosaccharides (Gos), Inulin, Resistant Starch, Beta-Glucans, Arabinogalactans, Pectins

    2) By Probiotics: Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Bacillus, Escherichia

    3) By Drugs: Antibiotics, Bacteriophage Therapy, Gut Microbiota Modulators, Immunomodulators, Antidiarrheal Agents, Laxatives

    4) By Supplements: Synbiotics, Postbiotics, Enzyme Supplements, Vitamin D Supplements, Omega-3 Fatty Acids, Herbal Extracts

    5) By Other Products: Functional Foods, Fermented Foods, Beverages, Gut Health Diagnostic Kits, Dietary Fiber Products

    Gut Microbiota Market Trends Reshaping Industry Growth

    Within the gut microbiota sector, leading enterprises are prioritizing the creation of novel approaches, including ingestible fecal microbiota treatments, to combat a spectrum of digestive ailments. This oral administration technique involves consuming a capsule or tablet containing beneficial microbes sourced from a healthy individual’s stool, with the aim of re-establishing equilibrium in the intestinal ecosystem. As an illustration, during April 2023, Seres Therapeutics Inc., a biomedical firm based in the United States specializing in microbiome therapies, secured authorization from the FDA for Vowst, the inaugural oral fecal microbiota therapy aimed at preventing the recurrence of Clostridioides difficile infections (CDI) in adults over 18. Vowst is prescribed for use subsequent to antibiotic interventions for recurring CDI, representing a substantial leap forward in managing this condition by offering a more convenient and patient-centric option compared to conventional fecal microbiota transplants administered through invasive procedures like colonoscopy or enemas, potentially enhancing treatment compliance and broader acceptance of microbiome therapies in medical practice.

    Gut Microbiota Market Industry Leaders And Market Competition

    Major companies operating in the gut microbiota market are Danone S.A., DuPont de Nemours Inc., International Flavors & Fragrances Inc., Seres Therapeutics, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., Lifeway Foods Inc., BioGaia AB, Probi AB, Seed Health, Enterome, Vedanta Biosciences Inc., Evolve BioSystems Inc., Winclove Probiotics B.V., Kallyope Inc., Sun Genomics Inc., Synlogic Inc., OpenBiome, Codex Labs Corp.

    Access The Complete Gut Microbiota Market Report:

    https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

    Gut Microbiota Market Largest Region By Revenue And Market Share

    North Americawas the largest region in the gut microbiota market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Gut Microbiota Market Forecast Signals New Revenue Opportunities Through 2030

    Gut Microbiota Market Forecast Signals New Revenue Opportunities Through 2030

    Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

    Gut Microbiota Market Expansion From $0.76 Billion In 2026 To $1.47 Billion In 2030

    The global gut microbiota market experienced significant expansion, projected to increase from $0.65 billion in 2025 to $0.77 billion by 2026, reflecting a compound annual growth rate of 18.0%. This notable growth throughout the historical period was fueled by several factors, including a deepening comprehension of the connection between gut health and the immune system, a surge in the consumption of dietary supplements, the burgeoning functional foods sector, intensified academic exploration into microbiota, and heightened consumer consciousness regarding digestive well-being.

    The microbiome therapeutics market is poised for significant expansion, with projections indicating a value of $1.47 billion by 2030, reflecting a compounded annual growth rate of 17.7% during this period. This upward trajectory is anticipated to be fueled by advancements in therapies aimed at the microbiome, heightened financial backing for gut health studies, the proliferation of individualized nutritional approaches, greater incorporation of microbiome-based diagnostics, and an escalating emphasis on proactive health strategies. Key developments expected to shape this market include a broader acceptance of probiotic and prebiotic offerings, a amplified concentration on bespoke dietary plans, intensified research into treatments derived from the microbiome, and an increase in the consumption of foods that are both functional and fermented, alongside more sophisticated utilization of diagnostic instruments for assessing gut health.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=23411&type=smp

    Gut Microbiota Market Growth Momentum: Which Factors Are Influencing Demand?

    The expansion of the gut microbiota market is anticipated to be fueled by the increasing interest in personalized medicine. This approach to healthcare focuses on customizing therapies based on a patient’s unique genetic makeup, environmental influences, and daily habits, ultimately aiming to enhance therapeutic results and elevate the standard of care. As technological progress in genomics and biotechnology allows for a more accurate understanding of genetic predispositions, the development of treatments specifically designed for individuals, thereby boosting efficacy and minimizing adverse reactions, is gaining traction. In relation to gut microbiota, personalized medicine plays a crucial role by developing therapies that consider an individual’s specific microbiome profile, thereby fostering optimal gut health and leading to better management of digestive and metabolic conditions. Demonstrating this trend, the U.S. Food and Drug Administration (FDA) authorized 26 novel personalized medicines in 2023, a notable increase from the 12 approvals in 2022, according to the Personalized Medicine Coalition (PMC), a non-profit entity based in the United States, as reported in February 2024. Consequently, the escalating demand for personalized medicine is acting as a significant catalyst for the growth of the gut microbiota market.

    Gut Microbiota Market Segment Landscape: Which Areas Lead Market Development?

    The gut microbiota market covered in this report is segmented –

    1) By Product: Prebiotics, Probiotics, Drugs, Supplements, Other Products

    2) By Application: Digestive Health, Immune Health, Weight Management, Mental Health, Cardiovascular Health

    3) By Distribution Channel: Pharmacies And Drugstores, Online Retail, Health Food Stores, Supermarkets And Hypermarkets, Specialty Stores

    4) By End-Users: Adults, Children, Elderly

    Subsegments:

    1) By Prebiotics: Fructooligosaccharides (Fos), Galactooligosaccharides (Gos), Inulin, Resistant Starch, Beta-Glucans, Arabinogalactans, Pectins

    2) By Probiotics: Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Bacillus, Escherichia

    3) By Drugs: Antibiotics, Bacteriophage Therapy, Gut Microbiota Modulators, Immunomodulators, Antidiarrheal Agents, Laxatives

    4) By Supplements: Synbiotics, Postbiotics, Enzyme Supplements, Vitamin D Supplements, Omega-3 Fatty Acids, Herbal Extracts

    5) By Other Products: Functional Foods, Fermented Foods, Beverages, Gut Health Diagnostic Kits, Dietary Fiber Products

    Gut Microbiota Market Trends Reshaping Industry Growth

    Within the gut microbiota sector, leading enterprises are prioritizing the creation of novel approaches, including ingestible fecal microbiota treatments, to combat a spectrum of digestive ailments. This oral administration technique involves consuming a capsule or tablet containing beneficial microbes sourced from a healthy individual’s stool, with the aim of re-establishing equilibrium in the intestinal ecosystem. As an illustration, during April 2023, Seres Therapeutics Inc., a biomedical firm based in the United States specializing in microbiome therapies, secured authorization from the FDA for Vowst, the inaugural oral fecal microbiota therapy aimed at preventing the recurrence of Clostridioides difficile infections (CDI) in adults over 18. Vowst is prescribed for use subsequent to antibiotic interventions for recurring CDI, representing a substantial leap forward in managing this condition by offering a more convenient and patient-centric option compared to conventional fecal microbiota transplants administered through invasive procedures like colonoscopy or enemas, potentially enhancing treatment compliance and broader acceptance of microbiome therapies in medical practice.

    Gut Microbiota Market Industry Leaders And Market Competition

    Major companies operating in the gut microbiota market are Danone S.A., DuPont de Nemours Inc., International Flavors & Fragrances Inc., Seres Therapeutics, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., Lifeway Foods Inc., BioGaia AB, Probi AB, Seed Health, Enterome, Vedanta Biosciences Inc., Evolve BioSystems Inc., Winclove Probiotics B.V., Kallyope Inc., Sun Genomics Inc., Synlogic Inc., OpenBiome, Codex Labs Corp.

    Access The Complete Gut Microbiota Market Report:

    https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

    Gut Microbiota Market Largest Region By Revenue And Market Share

    North Americawas the largest region in the gut microbiota market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Gut Microbiota Market Forecast Signals New Revenue Opportunities Through 2030

    Gut Microbiota Market Forecast Signals New Revenue Opportunities Through 2030

    Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

    Gut Microbiota Market Expansion From $0.76 Billion In 2026 To $1.47 Billion In 2030

    The global gut microbiota market experienced significant expansion, projected to increase from $0.65 billion in 2025 to $0.77 billion by 2026, reflecting a compound annual growth rate of 18.0%. This notable growth throughout the historical period was fueled by several factors, including a deepening comprehension of the connection between gut health and the immune system, a surge in the consumption of dietary supplements, the burgeoning functional foods sector, intensified academic exploration into microbiota, and heightened consumer consciousness regarding digestive well-being.

    The microbiome therapeutics market is poised for significant expansion, with projections indicating a value of $1.47 billion by 2030, reflecting a compounded annual growth rate of 17.7% during this period. This upward trajectory is anticipated to be fueled by advancements in therapies aimed at the microbiome, heightened financial backing for gut health studies, the proliferation of individualized nutritional approaches, greater incorporation of microbiome-based diagnostics, and an escalating emphasis on proactive health strategies. Key developments expected to shape this market include a broader acceptance of probiotic and prebiotic offerings, a amplified concentration on bespoke dietary plans, intensified research into treatments derived from the microbiome, and an increase in the consumption of foods that are both functional and fermented, alongside more sophisticated utilization of diagnostic instruments for assessing gut health.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=23411&type=smp

    Gut Microbiota Market Growth Momentum: Which Factors Are Influencing Demand?

    The expansion of the gut microbiota market is anticipated to be fueled by the increasing interest in personalized medicine. This approach to healthcare focuses on customizing therapies based on a patient’s unique genetic makeup, environmental influences, and daily habits, ultimately aiming to enhance therapeutic results and elevate the standard of care. As technological progress in genomics and biotechnology allows for a more accurate understanding of genetic predispositions, the development of treatments specifically designed for individuals, thereby boosting efficacy and minimizing adverse reactions, is gaining traction. In relation to gut microbiota, personalized medicine plays a crucial role by developing therapies that consider an individual’s specific microbiome profile, thereby fostering optimal gut health and leading to better management of digestive and metabolic conditions. Demonstrating this trend, the U.S. Food and Drug Administration (FDA) authorized 26 novel personalized medicines in 2023, a notable increase from the 12 approvals in 2022, according to the Personalized Medicine Coalition (PMC), a non-profit entity based in the United States, as reported in February 2024. Consequently, the escalating demand for personalized medicine is acting as a significant catalyst for the growth of the gut microbiota market.

    Gut Microbiota Market Segment Landscape: Which Areas Lead Market Development?

    The gut microbiota market covered in this report is segmented –

    1) By Product: Prebiotics, Probiotics, Drugs, Supplements, Other Products

    2) By Application: Digestive Health, Immune Health, Weight Management, Mental Health, Cardiovascular Health

    3) By Distribution Channel: Pharmacies And Drugstores, Online Retail, Health Food Stores, Supermarkets And Hypermarkets, Specialty Stores

    4) By End-Users: Adults, Children, Elderly

    Subsegments:

    1) By Prebiotics: Fructooligosaccharides (Fos), Galactooligosaccharides (Gos), Inulin, Resistant Starch, Beta-Glucans, Arabinogalactans, Pectins

    2) By Probiotics: Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Bacillus, Escherichia

    3) By Drugs: Antibiotics, Bacteriophage Therapy, Gut Microbiota Modulators, Immunomodulators, Antidiarrheal Agents, Laxatives

    4) By Supplements: Synbiotics, Postbiotics, Enzyme Supplements, Vitamin D Supplements, Omega-3 Fatty Acids, Herbal Extracts

    5) By Other Products: Functional Foods, Fermented Foods, Beverages, Gut Health Diagnostic Kits, Dietary Fiber Products

    Gut Microbiota Market Trends Reshaping Industry Growth

    Within the gut microbiota sector, leading enterprises are prioritizing the creation of novel approaches, including ingestible fecal microbiota treatments, to combat a spectrum of digestive ailments. This oral administration technique involves consuming a capsule or tablet containing beneficial microbes sourced from a healthy individual’s stool, with the aim of re-establishing equilibrium in the intestinal ecosystem. As an illustration, during April 2023, Seres Therapeutics Inc., a biomedical firm based in the United States specializing in microbiome therapies, secured authorization from the FDA for Vowst, the inaugural oral fecal microbiota therapy aimed at preventing the recurrence of Clostridioides difficile infections (CDI) in adults over 18. Vowst is prescribed for use subsequent to antibiotic interventions for recurring CDI, representing a substantial leap forward in managing this condition by offering a more convenient and patient-centric option compared to conventional fecal microbiota transplants administered through invasive procedures like colonoscopy or enemas, potentially enhancing treatment compliance and broader acceptance of microbiome therapies in medical practice.

    Gut Microbiota Market Industry Leaders And Market Competition

    Major companies operating in the gut microbiota market are Danone S.A., DuPont de Nemours Inc., International Flavors & Fragrances Inc., Seres Therapeutics, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., Lifeway Foods Inc., BioGaia AB, Probi AB, Seed Health, Enterome, Vedanta Biosciences Inc., Evolve BioSystems Inc., Winclove Probiotics B.V., Kallyope Inc., Sun Genomics Inc., Synlogic Inc., OpenBiome, Codex Labs Corp.

    Access The Complete Gut Microbiota Market Report:

    https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

    Gut Microbiota Market Largest Region By Revenue And Market Share

    North Americawas the largest region in the gut microbiota market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Gut microbiota market forecast with demand and growth insights

    Gut microbiota market forecast with demand and growth insights

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Much Will The Market Value Of The Gut Microbiota Market Grow Between 2026 And 2030?

    The gut microbiota market size has experienced rapid growth in recent years. It is projected to expand from $0.65 billion in 2025 to $0.77 billion in 2026, achieving a compound annual growth rate (CAGR) of 18.0%. The growth observed in the past can be attributed to an enhanced understanding of gut health and immunity, an increase in dietary supplement consumption, the expansion of functional food markets, a rise in academic research on microbiota, and growing consumer awareness of digestive health.

    The gut microbiota market is anticipated to experience substantial expansion in the coming years, projected to reach $1.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.7%.

    This growth during the forecast period is propelled by factors such as the intensified development of therapeutics aimed at the microbiome, increased investments in gut health research, the broadening of personalized nutrition platforms, the wider adoption of microbiome diagnostics, and a heightened emphasis on preventive healthcare solutions. Key trends expected over this period involve a greater uptake of probiotic and prebiotic items, an escalating interest in personalized nutrition strategies, advancements in research for microbiome-based treatments, the wider consumption of functional and fermented foods, and improved utilization of gut health diagnostic instruments.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

    What Key Factors Are Shaping The Gut Microbiota Market Landscape?

    The escalating need for personalized medicine is projected to drive the expansion of the gut microbiota market going forward. Personalized medicine entails tailoring medical interventions to individual patients based on their genetic, environmental, and lifestyle characteristics to optimize results and enhance care. The demand for personalized medicine is on the rise as breakthroughs in genomics and biotechnology facilitate more accurate identification of genetic profiles, enabling customized treatments that improve efficacy and mitigate adverse effects. Personalized medicine benefits gut microbiota by adapting treatments according to an individual’s unique microbiome composition, thereby enhancing gut health and improving outcomes for various digestive and metabolic disorders. For instance, in February 2024, data from the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, indicated that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, marking a significant rise compared to the 12 approved in 2022. Consequently, the increasing demand for personalized medicine is fueling the growth of the gut microbiota market.

    How Is The Gut Microbiota Market Broken Down By Segment Categories?

    The gut microbiota market covered in this report is segmented –

    1) By Product: Prebiotics, Probiotics, Drugs, Supplements, Other Products

    2) By Application: Digestive Health, Immune Health, Weight Management, Mental Health, Cardiovascular Health

    3) By Distribution Channel: Pharmacies And Drugstores, Online Retail, Health Food Stores, Supermarkets And Hypermarkets, Specialty Stores

    4) By End-Users: Adults, Children, Elderly

    Subsegments:

    1) By Prebiotics: Fructooligosaccharides (Fos), Galactooligosaccharides (Gos), Inulin, Resistant Starch, Beta-Glucans, Arabinogalactans, Pectins

    2) By Probiotics: Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Bacillus, Escherichia

    3) By Drugs: Antibiotics, Bacteriophage Therapy, Gut Microbiota Modulators, Immunomodulators, Antidiarrheal Agents, Laxatives

    4) By Supplements: Synbiotics, Postbiotics, Enzyme Supplements, Vitamin D Supplements, Omega-3 Fatty Acids, Herbal Extracts

    5) By Other Products: Functional Foods, Fermented Foods, Beverages, Gut Health Diagnostic Kits, Dietary Fiber Products

    What Market Trends Are Affecting The Gut Microbiota Market?

    Leading companies in the gut microbiota market are concentrating on developing innovative solutions, such as orally administered fecal microbiota, to address various gastrointestinal diseases and disorders. Orally administered fecal microbiota refers to a treatment where a capsule or pill containing beneficial bacteria from a healthy donor’s stool is consumed to restore balance to the gut microbiome. For instance, in April 2023, Seres Therapeutics Inc., a US-based microbiome therapeutics platform company, received FDA approval for Vowst, which is the first oral fecal microbiota product designed to prevent recurrent Clostridioides difficile (C. difficile) infection (CDI) in individuals aged 18 and older. Vowst is intended for use after antibacterial treatment for recurrent CDI. This approval signifies a significant advancement in CDI treatment, offering a more accessible and patient-friendly alternative to traditional fecal microbiota transplants, which are typically administered via colonoscopy or enema. Its oral formulation may enhance treatment adherence and expand the adoption of microbiome-based therapies in healthcare.

    Which Players Are Present In The Gut Microbiota Market Space?

    Major companies operating in the gut microbiota market are Danone S.A., DuPont de Nemours Inc., International Flavors & Fragrances Inc., Seres Therapeutics, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., Lifeway Foods Inc., BioGaia AB, Probi AB, Seed Health, Enterome, Vedanta Biosciences Inc., Evolve BioSystems Inc., Winclove Probiotics B.V., Kallyope Inc., Sun Genomics Inc., Synlogic Inc., OpenBiome, Codex Labs Corp.

    Get The Full Gut Microbiota Market Report:

    https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

    Which Region Holds The Highest Market Share In The Gut Microbiota Market?

    North America was the largest region in the gut microbiota market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Gut Microbiota Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

    Browse Through More Reports Similar to the Global Gut Microbiota Market 2026, By The Business Research Company

    Probiotics Food And Cosmetics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/probiotics-food-and-cosmetics-global-market-report

    Microbiomes Market Report 2026

    https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report

    Probiotics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/probiotics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • A significant industry trend in the Gut Microbiota Market includes the Advancements In Microbiota Profiling For Early Disease Detection And Personalized Treatments

    A significant industry trend in the Gut Microbiota Market includes the Advancements In Microbiota Profiling For Early Disease Detection And Personalized Treatments

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Size Expansion Is Predicted For The Gut Microbiota Market Between 2026 And 2030?

    The gut microbiota market size has seen rapid expansion in recent years. It is anticipated to grow from $0.65 billion in 2025 to $0.77 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 18.0%. The growth observed in previous periods can be linked to an enhanced understanding of gut health and immunity, a rise in dietary supplement consumption, the development of functional food markets, increased academic study on microbiota, and heightened consumer awareness of digestive health.

    The gut microbiota market size is anticipated to experience substantial growth in the upcoming years, with projections indicating it will reach $1.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.7%. This expansion during the forecast period is primarily driven by the increasing advancement of microbiome-targeted therapeutics, heightened investments in gut health research, the broadening of personalized nutrition platforms, the greater integration of microbiome diagnostics, and an increased emphasis on preventive healthcare solutions. Prominent trends expected over this period include a rising adoption of probiotic and prebiotic products, a growing focus on personalized nutrition solutions, expanding research in microbiome-based therapies, an increase in the consumption of functional and fermented foods, and enhanced utilization of gut health diagnostic tools.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=23411&type=smp

    What Major Drivers Are Influencing Demand In The Gut Microbiota Market?

    The increasing need for personalized medicine is anticipated to spur the expansion of the gut microbiota market moving forward. Personalized medicine entails customizing treatments for individual patients based on their genetic, environmental, and lifestyle elements to maximize outcomes and enhance care. The demand for personalized medicine is on the rise as breakthroughs in genomics and biotechnology enable more precise identification of genetic profiles, facilitating tailored treatments that improve efficacy and reduce adverse effects. Personalized medicine offers utility for gut microbiota by adapting therapies according to an individual’s unique microbiome composition, thereby optimizing gut health and enhancing results for digestive and metabolic disorders. For instance, in February 2024, as per the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, which was a notable surge compared to the 12 approved in 2022. Thus, the escalating demand for personalized medicine is propelling the growth of the gut microbiota market.

    Which Market Segments Are Examined In The Gut Microbiota Market Study?

    The gut microbiota market covered in this report is segmented –

    1) By Product: Prebiotics, Probiotics, Drugs, Supplements, Other Products

    2) By Application: Digestive Health, Immune Health, Weight Management, Mental Health, Cardiovascular Health

    3) By Distribution Channel: Pharmacies And Drugstores, Online Retail, Health Food Stores, Supermarkets And Hypermarkets, Specialty Stores

    4) By End-Users: Adults, Children, Elderly

    Subsegments:

    1) By Prebiotics: Fructooligosaccharides (Fos), Galactooligosaccharides (Gos), Inulin, Resistant Starch, Beta-Glucans, Arabinogalactans, Pectins

    2) By Probiotics: Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Bacillus, Escherichia

    3) By Drugs: Antibiotics, Bacteriophage Therapy, Gut Microbiota Modulators, Immunomodulators, Antidiarrheal Agents, Laxatives

    4) By Supplements: Synbiotics, Postbiotics, Enzyme Supplements, Vitamin D Supplements, Omega-3 Fatty Acids, Herbal Extracts

    5) By Other Products: Functional Foods, Fermented Foods, Beverages, Gut Health Diagnostic Kits, Dietary Fiber Products

    How Are Trends Impacting The Gut Microbiota Market?

    Leading companies active in the gut microbiota market are concentrating on developing innovative solutions, such as orally delivered fecal microbiota, to address various gastrointestinal ailments and conditions. Orally administered fecal microbiota refers to a treatment where a capsule or pill containing beneficial bacteria from a healthy donor’s stool is consumed to restore balance in the gut microbiome. For instance, in April 2023, Seres Therapeutics Inc., a US-based microbiome therapeutics platform company, secured FDA approval for Vowst, which is the first oral fecal microbiota product created to prevent recurrent Clostridioides difficile (C. difficile) infection (CDI) in individuals aged 18 and older. Vowst is intended for administration after antibacterial treatment for recurrent CDI. This approval represents a significant step forward in CDI treatment, offering a more accessible and patient-friendly alternative to traditional fecal microbiota transplants, which are typically delivered via colonoscopy or enema. Its oral formulation has the potential to improve treatment adherence and widen the adoption of microbiome-based therapies within healthcare.

    Who Are The Primary Competitors In The Gut Microbiota Market?

    Major companies operating in the gut microbiota market are Danone S.A., DuPont de Nemours Inc., International Flavors & Fragrances Inc., Seres Therapeutics, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., Lifeway Foods Inc., BioGaia AB, Probi AB, Seed Health, Enterome, Vedanta Biosciences Inc., Evolve BioSystems Inc., Winclove Probiotics B.V., Kallyope Inc., Sun Genomics Inc., Synlogic Inc., OpenBiome, Codex Labs Corp.

    Read the full gut microbiota market report here:

    https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

    Which Region Shows The Strongest Potential For Future Growth In The Gut Microbiota Market?

    North America was the largest region in the gut microbiota market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Gut Microbiota Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=23411&type=smp

    Browse Through More Reports Similar to the Global Gut Microbiota Market 2026, By The Business Research Company

    Microbiomes Global Market Report

    https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report

    Probiotics Global Market Report

    https://www.thebusinessresearchcompany.com/report/probiotics-global-market-report

    Probiotics Food And Cosmetics Global Market Report

    https://www.thebusinessresearchcompany.com/report/probiotics-food-and-cosmetics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Gut Microbiota Market Performance Report: Global Trends 2026–2030

    Global Gut Microbiota Market Performance Report: Global Trends 2026–2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the gut microbiota market from 2026–2035 with trusted insights from The Business Research Company

    What level of CAGR-driven expansion is anticipated in the Gut Microbiota Market between 2026 and 2030?

    The gut microbiota market has experienced rapid expansion in recent years. This market is set to increase from $0.65 billion in 2025 to $0.77 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 18.0%. The growth observed in the past can be attributed to several factors, including a better understanding of gut health and immunity, the growing consumption of dietary supplements, the expansion of functional food markets, an increase in academic research concerning microbiota, and heightened consumer awareness regarding digestive health.

    The gut microbiota market is projected for substantial expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $1.47 billion, exhibiting a compound annual growth rate (CAGR) of 17.7%. This projected growth is driven by several factors, including the escalating development of therapeutics targeting the microbiome, increased funding for gut health investigations, the broadening of personalized nutrition services, the wider adoption of microbiome diagnostic tools, and a greater emphasis on healthcare solutions focused on prevention. Key trends expected during this period involve a surge in the uptake of probiotic and prebiotic items, a heightened emphasis on customized nutritional approaches, an increase in research dedicated to microbiome-derived treatments, a rise in the consumption of functional and fermented foods, and improved utilization of diagnostic instruments for gut health.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=23411&type=smp

    What Drivers Are Affecting Demand-Supply Dynamics In The Gut Microbiota Market?

    The increasing need for individualized healthcare approaches is anticipated to drive expansion in the gut microbiota market in the future. This medical approach customizes therapies for specific patients, considering their genetic makeup, environmental influences, and lifestyle choices, with the aim of maximizing positive results and enhancing patient care. The demand for personalized medicine is on the rise, primarily due to breakthroughs in genomics and biotechnology that facilitate more accurate identification of genetic profiles, thereby enabling customized treatments that are more effective and have fewer adverse reactions. For gut microbiota, personalized medicine proves beneficial by adapting treatments according to a person’s distinct microbiome makeup, thereby optimizing gut health and enhancing results for conditions related to digestion and metabolism. As an illustration, in February 2024, data from the Personalized Medicine Coalition (PMC), a US-based nonprofit, revealed that the U.S. Food and Drug Administration (FDA) granted approval to 26 new personalized medicines in 2023, representing a notable increase from the 12 approved in 2022. Consequently, the escalating demand for personalized medicine is fueling the expansion of the gut microbiota market.

    How Is The Gut Microbiota Market Organized Into Various Segments?

    The gut microbiota market covered in this report is segmented –

    1) By Product: Prebiotics, Probiotics, Drugs, Supplements, Other Products

    2) By Application: Digestive Health, Immune Health, Weight Management, Mental Health, Cardiovascular Health

    3) By Distribution Channel: Pharmacies And Drugstores, Online Retail, Health Food Stores, Supermarkets And Hypermarkets, Specialty Stores

    4) By End-Users: Adults, Children, Elderly

    Subsegments:

    1) By Prebiotics: Fructooligosaccharides (Fos), Galactooligosaccharides (Gos), Inulin, Resistant Starch, Beta-Glucans, Arabinogalactans, Pectins

    2) By Probiotics: Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Bacillus, Escherichia

    3) By Drugs: Antibiotics, Bacteriophage Therapy, Gut Microbiota Modulators, Immunomodulators, Antidiarrheal Agents, Laxatives

    4) By Supplements: Synbiotics, Postbiotics, Enzyme Supplements, Vitamin D Supplements, Omega-3 Fatty Acids, Herbal Extracts

    5) By Other Products: Functional Foods, Fermented Foods, Beverages, Gut Health Diagnostic Kits, Dietary Fiber Products

    What Upcoming Trends Are Likely To Define The Future Path Of The Gut Microbiota Market?

    Leading companies within the gut microbiota sector are concentrating on creating novel solutions, such as orally delivered fecal microbiota, to address various gastrointestinal conditions and disorders. This approach involves a treatment where a capsule or pill, containing beneficial bacteria sourced from a healthy donor’s stool, is consumed to help restore equilibrium to the gut microbiome. For instance, in April 2023, Seres Therapeutics Inc., a US-based microbiome therapeutics platform company, secured FDA approval for Vowst. Vowst is the inaugural oral fecal microbiota product specifically formulated to prevent recurring Clostridioides difficile (C. difficile) infection (CDI) in individuals aged 18 and above, intended for administration following antibacterial treatment for recurrent CDI. This clearance represents a substantial progression in CDI management, offering a more convenient and patient-centric option compared to conventional fecal microbiota transplants, which are typically administered via colonoscopy or enema. Its oral preparation has the potential to enhance treatment compliance and broaden the integration of microbiome-based therapies within healthcare.

    Who Are The Core Companies Influencing Trends In The Gut Microbiota Market?

    Major companies operating in the gut microbiota market are Danone S.A., DuPont de Nemours Inc., International Flavors & Fragrances Inc., Seres Therapeutics, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., Lifeway Foods Inc., BioGaia AB, Probi AB, Seed Health, Enterome, Vedanta Biosciences Inc., Evolve BioSystems Inc., Winclove Probiotics B.V., Kallyope Inc., Sun Genomics Inc., Synlogic Inc., OpenBiome, Codex Labs Corp.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

    Which Region Is Expected To Experience The Fastest Growth In The Gut Microbiota Market?

    North America was the largest region in the gut microbiota market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Gut Microbiota Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=23411&type=smp

    Browse Through More Reports Similar to the Global Gut Microbiota Market 2026, By The Business Research Company

    Probiotics Food And Cosmetics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/probiotics-food-and-cosmetics-global-market-report

    Microbiomes Market Report 2026

    https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report

    Probiotics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/probiotics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • How Will The Gut Microbiota Market Reach $1.25 Billion By 2029 Amid Global Shifts?

    How Will The Gut Microbiota Market Reach $1.25 Billion By 2029 Amid Global Shifts?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    What Is The Predicted Market Size Of The Gut Microbiota Industry By 2029?

    The market size of gut microbiota has witnessed a rapid acceleration in growth in the past few years. The market is expected to expand from $0.55 billion in 2024 to $0.65 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 17.9%. This notable growth during the historic period is largely due to several factors including the discovery of pro and prebiotics, an increase in gastrointestinal disorders, a heightened interest in functional foods, the escalating usage of antibiotics, and enhanced awareness regarding the gut-brain axis.

    In the coming years, the gut microbiota market is predicted to experience a significant expansion. The market size will escalate to $1.25 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 17.9%. This projected growth during the forecast period can be linked to the broadening of personalized nutrition, increasing need for microbiome-related therapeutics, development in functional and fermented foods, and official backing for both probiotics and prebiotics. Predominant trends for the forecast period encompass the use of Artificial Intelligence (AI) for microbiome assessment, advancements in next-generation sequencing, gut microbiota tweaking with CRISPR, advancement of intelligent probiotic delivery mechanisms, and the use of wearable devices for monitoring gut health.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=23411&type=smp

    Which Industry Forces Are Driving The Gut Microbiota Market Forward?

    As personalized healthcare gains traction, it is anticipated to fuel the expansion of the gut microbiota market. Personalized healthcare customizes treatment plans based on a patient’s genetic makeup, environment and lifestyle factors to deliver optimal results and enhanced patient care. As advancements in genomics and biotech make it possible to pinpoint genetic profiles with increased accuracy, demand grows for personalized healthcare that allows for tailor-made treatments to enhance efficacy and limit side effects. With regard to gut microbiota, personalized healthcare optimizes gut health by customizing treatments based on an individual’s unique microbiome composition, thus enhancing outcomes for digestive and metabolic disorders. For instance, the U.S Food and Drug Administration (FDA), as reported by the Personalized Medicine Coalition (PMC), a non-profit organization based in the U.S, approved 26 new personalized medicines in 2023, a notable increase from the 12 approved in 2022. Consequently, the escalating demand for personalized healthcare is facilitating the growth of the gut microbiota market.

    What Is The Segment Breakdown Of The Gut Microbiota Market?

    The gut microbiotamarket covered in this report is segmented –

    1) By Product: Prebiotics; Probiotics; Drugs; Supplements; Other Products

    2) By Application: Digestive Health; Immune Health; Weight Management; Mental Health; Cardiovascular Health

    3) By Distribution Channel: Pharmacies And Drugstores; Online Retail; Health Food Stores; Supermarkets And Hypermarkets; Specialty Stores

    4) By End-Users: Adults; Children; Elderly

    Subsegments:

    1) By Prebiotics: Fructooligosaccharides (Fos); Galactooligosaccharides (Gos); Inulin; Resistant Starch; Beta-Glucans; Arabinogalactans; Pectins

    2) By Probiotics: Lactobacillus; Bifidobacterium; Saccharomyces; Streptococcus; Bacillus; Escherichia

    3) By Drugs: Antibiotics; Bacteriophage Therapy; Gut Microbiota Modulators; Immunomodulators; Antidiarrheal Agents; Laxatives

    4) By Supplements: Synbiotics; Postbiotics; Enzyme Supplements; Vitamin D Supplements; Omega-3 Fatty Acids; Herbal Extracts

    5) By Other Products: Functional Foods; Fermented Foods; Beverages; Gut Health Diagnostic Kits; Dietary Fiber Products

    What Are The Dominant Trends Currently Seen In The Gut Microbiota Market?

    Leading businesses in the gut microbiota market are concentrating on creating innovative solutions, like orally administered fecal microbiota, to tackle a variety of gastrointestinal illnesses and conditions. This form of treatment involves taking a pill or capsule filled with beneficial bacteria from a healthy donor’s feces to restore equilibrium to the gut microbiome. In the example of Seres Therapeutics Inc., a US-based microbiome therapeutics platform company, they received FDA approval in April 2023 for Vowst, the first oral fecal microbiota product developed to prevent the recurrence of Clostridioides difficile infection (C. difficile) in adults aged 18 and over. The product, Vowst, is to be used post-antibacterial treatment for recurrent CDI. Such an approval indicates considerable progress in CDI treatment, offering a more user-friendly and accessible alternative to the conventional fecal microbiota transplants often delivered via colonoscopy or enema. The oral composition of this treatment could enhance treatment compliance and promote the wider acceptance of microbiome-based therapies in the medical field.

    Which Companies Are Contributing Significantly To The Gut Microbiota Market Growth?

    Major companies operating in the gut microbiota market are Danone S.A., DuPont de Nemours Inc., International Flavors & Fragrances Inc., Seres Therapeutics, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., Lifeway Foods Inc., BioGaia AB, Probi AB, Seed Health, Enterome, Vedanta Biosciences Inc., Evolve BioSystems Inc., Winclove Probiotics B.V., Kallyope Inc., Sun Genomics Inc., Synlogic Inc., OpenBiome, Codex Labs Corp.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

    Which Region Is Leading Innovation In The Gut Microbiota Market?

    North America was the largest region in the gut microbiota market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=23411&type=smp

    Browse Through More Reports Similar to the Global Gut Microbiota Market 2025, By The Business Research Company

    Animal Intestinal Health Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/animal-intestinal-health-global-market-report

    Disposable Intestinal Wash Bags Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/disposable-intestinal-wash-bags-global-market-report

    Gastrointestinal Drug Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Gut Microbiota Market Size Forecast: Revenue and CAGR by 2029

    Gut Microbiota Market Size Forecast: Revenue and CAGR by 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    What Is The Global Market Value Of The Gut Microbiota Industry In 2025?

    The gut microbiota market has experienced substantial expansion in recent years. It is anticipated to increase from $0.55 billion in 2024 to $0.65 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 17.9%. This historical growth can be ascribed to factors such as the discovery of probiotics and prebiotics, the rising prevalence of gastrointestinal disorders, growing consumer interest in functional foods, the expanded use of antibiotics, and increased awareness regarding the gut-brain axis.

    The gut microbiota market is forecast to experience substantial expansion in the upcoming years. It is predicted to reach a valuation of $1.25 billion by 2029, achieving a compound annual growth rate (CAGR) of 17.9%. This projected increase during the forecast period stems from the broadening scope of personalized nutrition, a rising consumer need for microbiome-based therapeutics, the expansion of functional and fermented food markets, and supportive regulatory frameworks for probiotics and prebiotics. Key developments anticipated in this period include artificial intelligence (AI)-driven microbiome analysis, advancements in next-generation sequencing, CRISPR-based gut microbiota editing, the invention of smart probiotic delivery systems, and wearable devices designed for gut health monitoring.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=23411&type=smp

    What Are The Main Drivers Boosting The Gut Microbiota Industry’s Expansion?

    The increasing requirement for personalized medical treatments is projected to fuel the expansion of the gut microbiota market moving forward. Personalized medicine involves customizing treatments for individual patients based on their genetic, environmental, and lifestyle factors to achieve optimal outcomes and improve care. The demand for personalized medicine is escalating due to advancements in genomics and biotechnology, which allow for more precise identification of genetic profiles, leading to tailored treatments that enhance effectiveness and reduce adverse effects. Personalized medicine benefits the gut microbiota by enabling customized treatments based on an individual’s distinct microbiome composition, thereby optimizing gut health and improving results for digestive and metabolic disorders. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, which was a notable increase compared to the 12 approved in 2022. Therefore, the growing need for personalized medicine is driving the growth of the gut microbiota market.

    What Are The Key Segments In The Gut Microbiota Market?

    The gut microbiotamarket covered in this report is segmented –

    1) By Product: Prebiotics; Probiotics; Drugs; Supplements; Other Products

    2) By Application: Digestive Health; Immune Health; Weight Management; Mental Health; Cardiovascular Health

    3) By Distribution Channel: Pharmacies And Drugstores; Online Retail; Health Food Stores; Supermarkets And Hypermarkets; Specialty Stores

    4) By End-Users: Adults; Children; Elderly

    Subsegments:

    1) By Prebiotics: Fructooligosaccharides (Fos); Galactooligosaccharides (Gos); Inulin; Resistant Starch; Beta-Glucans; Arabinogalactans; Pectins

    2) By Probiotics: Lactobacillus; Bifidobacterium; Saccharomyces; Streptococcus; Bacillus; Escherichia

    3) By Drugs: Antibiotics; Bacteriophage Therapy; Gut Microbiota Modulators; Immunomodulators; Antidiarrheal Agents; Laxatives

    4) By Supplements: Synbiotics; Postbiotics; Enzyme Supplements; Vitamin D Supplements; Omega-3 Fatty Acids; Herbal Extracts

    5) By Other Products: Functional Foods; Fermented Foods; Beverages; Gut Health Diagnostic Kits; Dietary Fiber Products

    Which Market Trends Are Creating New Opportunities In The Gut Microbiota Industry?

    Leading companies in the gut microbiota market are concentrating on creating innovative solutions, such as orally delivered fecal microbiota, to tackle various gastrointestinal diseases and disorders. Orally administered fecal microbiota describes a treatment involving the intake of a capsule or pill filled with beneficial bacteria from a healthy donor’s stool to re-establish balance in the gut microbiome. For instance, in April 2023, Seres Therapeutics Inc., a US-based microbiome therapeutics platform company, secured FDA approval for Vowst, which is the first oral fecal microbiota product developed to prevent recurrent Clostridioides difficile (C. difficile) infection (CDI) in individuals aged 18 and older. Vowst is intended for use subsequent to antibacterial treatment for recurrent CDI. This approval signifies a notable advancement in CDI treatment, offering a more accessible and patient-friendly option compared to conventional fecal microbiota transplants, which are typically administered via colonoscopy or enema. Its oral formulation has the potential to enhance treatment adherence and broaden the adoption of microbiome-based therapies in healthcare.

    Which Industry Leaders Are Driving Innovation Across The Gut Microbiota Market?

    Major companies operating in the gut microbiota market are Danone S.A., DuPont de Nemours Inc., International Flavors & Fragrances Inc., Seres Therapeutics, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., Lifeway Foods Inc., BioGaia AB, Probi AB, Seed Health, Enterome, Vedanta Biosciences Inc., Evolve BioSystems Inc., Winclove Probiotics B.V., Kallyope Inc., Sun Genomics Inc., Synlogic Inc., OpenBiome, Codex Labs Corp.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

    How Is Gut Microbiota Market Demand Varying Across Different Regions?

    North America was the largest region in the gut microbiota market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The Gut Microbiota Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=23411&type=smp

    Browse Through More Reports Similar to the Global Gut Microbiota Market 2025, By The Business Research Company

    Animal Intestinal Health Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/animal-intestinal-health-global-market-report

    Disposable Intestinal Wash Bags Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/disposable-intestinal-wash-bags-global-market-report

    Gastrointestinal Drug Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Key Developments and Trends Steering the Gut Microbiota Market Forward: Advancements In Microbiota Profiling For Early Disease Detection And Personalized Treatments

    Key Developments and Trends Steering the Gut Microbiota Market Forward: Advancements In Microbiota Profiling For Early Disease Detection And Personalized Treatments

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Has The Gut Microbiota Market Growth Evolved From 2024 To 2025, And What’s Ahead?

    The size of the gut microbiota market has seen swift expansion in the past few years. Increasing from $0.55 billion in 2024, it’s projected to expand to $0.65 billion in 2025, indicating a compound annual growth rate (CAGR) of 17.9%. Factors such as the unveil of probiotics and prebiotics, a surge in gastrointestinal conditions, rising interest in functional foods, the escalating usage of antibiotics, and heightened awareness about the gut-brain connection have all contributed to growth during the historical period.

    The market for gut microbiota is projected to experience a swift expansion in the coming years, reaching a valuation of $1.25 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 17.9%. The predicted augmentation in the forecast period can be linked to factors such as the increase in personalized nutrition, a surge in demand for microbiome-related therapeutics, growth in the sector of functional and fermented foods, and regulatory encouragement for probiotics and prebiotics. Key trends anticipated in the forecast period include the utilization of artificial Intelligence (AI) for microbiome examination, developments in next-generation sequencing, the use of CRISPR for editing gut microbiota, improvements in intelligent probiotic delivery systems, and the advent of wearable devices specifically designed for monitoring gut health.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=23411&type=smp

    How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theGut Microbiota Market?

    The surge in personalized medicine demand is believed to be a driving force for the expansion of the gut microbiota market in the future. Personalized medicine is focused on customizing treatments to individual patients, taking into account their genetic makeup, environment, and lifestyle choices. This approach aims to optimize results and enhance care quality. The field of genomics and biotechnology is advancing rapidly, allowing detailed genetic profiling and enabling more effective personalized treatment plans with reduced side effects. Gut microbiota greatly benefits from personalized medicine as it allows treatment procedures to be tailored based on a person’s distinct microbiome composition, thus maximizing gut health and improving outcomes for metabolic and digestive disorders. As an example, the Personalized Medicine Coalition (PMC), a nonprofit organization based in the USA, reported in February 2024 that the U.S. Food and Drug Administration (FDA) authorized 26 personalized medicines in 2023. This figure shows a considerable increase from the 12 endorsements given in the previous year, 2022. Consequently, the booming demand for personalized medicine is stimulating the growth of the gut microbiota market.

    Which Segments in the Gut Microbiota Offer the Most Growth?

    The gut microbiotamarket covered in this report is segmented –

    1) By Product: Prebiotics; Probiotics; Drugs; Supplements; Other Products

    2) By Application: Digestive Health; Immune Health; Weight Management; Mental Health; Cardiovascular Health

    3) By Distribution Channel: Pharmacies And Drugstores; Online Retail; Health Food Stores; Supermarkets And Hypermarkets; Specialty Stores

    4) By End-Users: Adults; Children; Elderly

    Subsegments:

    1) By Prebiotics: Fructooligosaccharides (Fos); Galactooligosaccharides (Gos); Inulin; Resistant Starch; Beta-Glucans; Arabinogalactans; Pectins

    2) By Probiotics: Lactobacillus; Bifidobacterium; Saccharomyces; Streptococcus; Bacillus; Escherichia

    3) By Drugs: Antibiotics; Bacteriophage Therapy; Gut Microbiota Modulators; Immunomodulators; Antidiarrheal Agents; Laxatives

    4) By Supplements: Synbiotics; Postbiotics; Enzyme Supplements; Vitamin D Supplements; Omega-3 Fatty Acids; Herbal Extracts

    5) By Other Products: Functional Foods; Fermented Foods; Beverages; Gut Health Diagnostic Kits; Dietary Fiber Products

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=23411&type=smp

    What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theGut Microbiota Market?# Market?

    North America was the largest region in the gut microbiota market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Are the Current Market Growth and Trends in the Gut Microbiota Industry?

    Key firms in the gut microbiota market are working toward creating groundbreaking solutions such as orally consumed fecal microbiota for treating numerous gastrointestinal issues. This treatment involves taking a pill or capsule that contains useful bacteria sourced from a healthy donor’s stool, with the goal of restoring balance to the gut microbiome. In April 2023, the US firm Seres Therapeutics Inc., a key player in the field of microbiome therapeutics, got FDA approval for Vowst – the very first orally consumed fecal microbiota product. This has been engineered to prevent recurrent C. difficile infection (CDI) in people aged 18 or above, to be used post antibacterial treatment for recurrent CDI. This approval constitutes a critical leap forward in CDI treatment, offering an alternative to traditional fecal microbiota transplants that is not only more accessible but also more patient-friendly, as these are usually administered via enema or colonoscopy. This oral formulation could boost adherence to treatment and widen the acceptance of microbiome-based therapies within the healthcare realm.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

    What Are the Key Elements That Define the Gut Microbiota Market?

    Gut microbiota refers to the complex community of microorganisms, including bacteria, viruses, fungi, and other microbes, that reside in the gastrointestinal tract. These microbes play a vital role in digestion, immune function, and overall health by influencing metabolism and protecting against harmful pathogens.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23411

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Gut Microbiota Market Trends Report 2025 – For Business Development and Strategy Teams

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Forecast for the Gut Microbiota Market Growth in 2025?

    Over the last few years, the gut microbiota market has seen quick expansion. The market size, which was at $0.55 billion in 2024, is projected to increase to $0.65 billion in 2025, representing a compound annual growth rate (CAGR) of 18.5%. Factors such as the identification of probiotics and prebiotics, growing instances of gastrointestinal disorders, a renewed interest in functional foods, increasing usage of antibiotics, and the surge in recognition of the gut-brain axis have contributed to the growth during the historic period.

    What Is the Forecast for the Gut Microbiota Market Size Through 2029?

    The market for gut microbiota is anticipated to experience swift expansion in the forthcoming years. The market value is projected to reach $1.27 billion in 2029, escalating at a compound annual growth rate (CAGR) of 18.2%. This projected growth during the forecast period can be credited to the growth of personalized nutrition, an increased interest in microbiome-based therapeutics, the popularity of fermented and functional foods, and support from regulatory bodies for prebiotics and probiotics. Key market trends during the forecast period are expected to include AI-enabled microbiome analysis, advancements in next-generation sequencing, gut microbiota editing using CRISPR, evolution of intelligent probiotic delivery systems, and wearable devices for gut health monitoring.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=23411&type=smp

    What are the Key Market Players in Gut Microbiota Market and How They’re Evolving?

    Major companies operating in the gut microbiota market are Danone S.A., DuPont de Nemours Inc., International Flavors & Fragrances Inc., Seres Therapeutics, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., Lifeway Foods Inc., BioGaia AB, Probi AB, Seed Health, Enterome, Vedanta Biosciences Inc., Evolve BioSystems Inc., Winclove Probiotics B.V., Kallyope Inc., Sun Genomics Inc., Synlogic Inc., OpenBiome, Codex Labs Corp.

    What Are the Primary Growth Drivers in the Gut Microbiota Market?

    The rise in the need for personalized medicine is anticipated to stimulate the expansion of the gut microbiota market. Personalized medicine takes into consideration an individual’s genetical, environmental, and lifestyle parameters to cater to treatments that enhance their health and deliver better care. With the progression of genomics and biotechnology, more accurate genetic profiling has become possible – leading to the personalization of treatments; enhancing their efficacy and minimizing their side effects. Personalized medicine, in the case of gut microbiota, helps in customizing treatments as per the unique composition of an individual’s microbiome. This optimizes the health of their gut, and advances outcomes for disorders related to metabolism and digestion. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a nonprofit organization based in the US, stated that the U.S. Food and Drug Administration (FDA) gave approval to 26 new personalized medicines in 2023. This was a momentous rise in comparison to the 12, which had been approved in the previous year, 2022. Hence, the escalating demand for personalized medicine is fueling the growth of the gut microbiota market.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=23411&type=smp

    What Are the Leading Segments in the Global Gut Microbiota Industry?

    The gut microbiota market covered in this report is segmented –

    1) By Product: Prebiotics, Probiotics, Drugs, Supplements, Other Products

    2) By Application: Digestive Health, Immune Health, Weight Management, Mental Health, Cardiovascular Health

    3) By Distribution Channel: Pharmacies And Drugstores, Online Retail, Health Food Stores, Super markets And Hyper markets, Specialty Stores

    4) By End-Users: Adults, Children, Elderly

    Subsegments:

    1) By Prebiotics: Fructooligosaccharides (Fos), Galactooligosaccharides (Gos), Inulin, Resistant Starch, Beta-Glucans, Arabinogalactans, Pectins

    2) By Probiotics: Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Bacillus, Escherichia

    3) By Drugs: Antibiotics, Bacteriophage Therapy, Gut Microbiota Modulators, Immunomodulators, Antidiarrheal Agents, Laxatives

    4) By Supplements: Synbiotics, Postbiotics, Enzyme Supplements, Vitamin D Supplements, Omega-3 Fatty Acids, Herbal Extracts

    5) By Other Products: Functional Foods, Fermented Foods, Beverages, Gut Health Diagnostic Kits, Dietary Fiber Products

    What Are the Key Market Trends in the Gut Microbiota Industry?

    Major corporations in the gut microbiota market are honing in on innovative strategies, such as fecal microbiota taken orally, to treat numerous digestive diseases and disorders. This form of treatment involves ingesting a tablet or capsule filled with beneficial bacteria from the stool of a healthy donor to reestablish equilibrium in the gut microbiome. For example, in April 2023, Seres Therapeutics Inc., a microbiome therapeutics firm based in the US, was granted FDA approval for Vowst, the first orally taken fecal microbiota product made to thwart recurring Clostridioides difficile (C. difficile) infection (CDI) in those aged 18 and up. Vowst is slated for use following antibiotic treatment for recurring CDI. This approval signifies a notable progression in CDI treatment, offering a more user-friendly and readily available substitute to traditional fecal microbiota transplants, which are typically given via colonoscopy or enema. Its oral formulation is likely to enhance treatment compliance and increase the acceptance of microbiome-based therapies in the medical sector.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

    What Is the Regional Outlook for the Gut Microbiota Market?

    North America was the largest region in the gut microbiota market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23411

    This Report Delivers Insight On:

    1. How big is the gut microbiota market, and how is it changing globally?

    2. Who are the major companies in the gut microbiota market, and how are they performing?

    3. What are the key opportunities and risks in the gut microbiota market right now?

    4. Which products or customer segments are growing the most in the gut microbiota market?

    5. What factors are helping or slowing down the growth of the gut microbiota market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model